PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsAgnitio
Agnitio
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
AtorvastatinAtorvastatin2021-09-022037
Hypercholesterolemia
,
Coronary artery disease
,
Hypertriglyceridemia
,
Hyperlipoproteinemias
,
Hypertension
,
Variant angina pectoris
,
Familial combined hyperlipidemia
,
Hyperlipoproteinemia type ii
Ethacrynic acidEthacrynic acid2019-07-12
Heart failure
,
Hypertension
,
Chronic kidney failure
,
Liver cirrhosis
,
Nephrotic syndrome
,
Edema
,
Ascites
,
Pulmonary edema
TriamtereneTriamterene2019-08-19
Heart failure
,
Hypertension
,
Nephrotic syndrome
,
Edema
,
Hypokalemia
PhytonadionePhytonadione2023-10-12
Hypercholesterolemia,
Hypophosphatemia,
Hypertriglyceridemia,
Peripheral vascular diseases,
Dermatitis,
Alcoholic neuropathy,
Common cold,
Seizures,
Vitamin a deficiency,
Hypoparathyroidism,
Inborn errors metabolism,
Photosensitivity disorders,
Methemoglobinemia,
Thiamine deficiency,
Folic acid deficiency,
Rickets,
Vitamin b 6 deficiency,
Megaloblastic anemia,
Vitamin b deficiency,
Xerophthalmia,
Penetrating wounds,
Tyrosinemias,
Wernicke encephalopathy,
Beriberi,
Scurvy,
Night blindness,
Riboflavin deficiency,
Pellagra
Clinical Trials
No data
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use